Therapeutics Company Receives Approval For Alcohol Use Disorder Treatment Trial

Clearmind Medicine Breaks New Ground with Approval for Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a significant development that is set to redefine the landscape of addiction therapy, Clearmind Medicine Inc. has received approval to initiate its Phase I/IIa clinical trial for CMND-100, a groundbreaking t…